Offentligt REU Alm.delBilag408 Retsudvalget 2013-14
Cannabis policy history, legacy and evidence Origins of cannabis control
1925 Geneva Convention on Opium 1930s prohibitionist movement
US influence in the UN diplomacy after world war II
2 Cannabis Classified as one of the most dangerous substances
3 UN Single Convention 1961 Schedule I Schedule II Schedule III Schedule IV Acetorphine Acetyldihydrocodein Preparations of AcetorphineAcetyl- AcetorphineAcetyl- Codeine Acetyldihydrocodein alpha-methylfentanyl alpha-methylfentanyl Dextropropoxyphen Codeine, Alphaprodine Dihydrocodeine DihydrocodeineEthylmo Beta-hydroxy-3- Betacetylmethadol Ethylmorphin rphine, Nicodicodine, methylfentanyl Beta-hydroxy-3- Nicocodine Norcodeine, Beta-hydroxyfentan methylfentanyl Nicodicodine Pholcodine Cannabis and Cannabis and Norcodeine Preparations of Cannabis resin Cannabis resin Pholcodine Propiram Desomorphine Coca leaf Propiram Preparations of Etorphine Cocaine Cocaine Heroin Desomorphine Ketobemidone Dipipanone 3-methylfentanyl Fentanyl 3-methylthiofentanyl Etorphine MPPP Heroin Para-fluorofentanyl Metazocine PEPAPThiofentanyl Methadone Morphine Opium Oxycodone
4 5 6 100 years of Governments or Parliaments studies on the effects of cannabis
1894 United Kingdom The Indian Hemp Drugs Commission 1925 Panama The Panama Canal Zone Report 1944 USA La Guardia Report 1969 United Kingdom the Wootton Report 1970 Canada Le Dain Report 1971 &1972 Netherlands Baan & Hulsman Commissions 1973 USA Shafer Commission 1971 & 1977 Australia Marriott Committee and the Baume Committee 1982 United Kingdom Report of the Expert Group on the Effects of Cannabis Use, Home Office Advisory Council on the Misuse of Drugs, Home Office 1994 Australia Commonwealth of Australia Legislative options for cannabis use 1998 United Kingdom House of Lord Science and Technology Select Committee, Ninth Report, Cannabis: the scientific and medical evidence, 1998 New Zealand Inquiry into the Mental Health Effects of Cannabis, Report of the Health Committee, AJHR, I.6A New Zealand,
7 100 years of Governments or Parliaments studies on the effects of cannabis
1999 Switzerland Swiss Federal Commission for Drug Issues, Cannabis Report, Federal Office of Public Health, Bern 2001 Jamaica A Report of the National Commission on Ganja to Rt. Hon. P.J. Patterson, Q.C., M. P. Prime Minister of Jamaica, 2002 United Kingdom Reports by the Advisory Council on Misuse of Drugs, Home Office, The Classification of Cannabis under the Misuse of Drugs Act 1971 2002 Canada The Senate Special Committee On Illegal Drugs, Cannabis: Our Position For A Canadian Public Policy, 2003 France Rapport de la Commission d’enquête su Sénat français sur la politique nationale de lutte contre les drogues illicites, N°321, 2005 United Kingdom Further Consideration of the Classification of Cannabis under the Misuse of Drugs Act 1971
8 Review of 100 years of official studies
1. Cannabis is not an harmless substance
2. The dangers have been overstated
3. Personal use offences do not require criminal sanctions Lancet 2010: Drug harms in the UK: a multicriteria decision analysis David J Nutt, Leslie A King, Lawrence D Phillips, on behalf of the Independent Scientific Committee on Drugs
10 Studies adverse effects from cannabis use
11 Cannabis – a political hot topic
Debates and controversies Most stringent classification Exaggeration and banalisation Centre of diplomatic attention among nations and scientific controversies